We attempt to identify target molecules for cancer therapy and diagnostic markers based on clinical and basic research approaches.
We are also conducting research on the three-dimensional genomic structure of cancer cells, because recent studies have revealed an association between an abnormal three-dimensional genome structure and cancer malignancy.